Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ATAI
Stock Latest News
Ratings
ATAI Life Sciences: Promising Outlook with Strategic Moves and Strong Financial Position
8d ago
ATAI
Premium
Ratings
ATAI Life Sciences: Positioned for Growth in Psychedelic Medicine with Promising Developments and Strategic Partnerships
11d ago
ATAI
Premium
Company Announcements
Atai Life Sciences Reports Q2 2025 Financial Results
11d ago
ATAI
Premium
Ratings
ATAI Life Sciences: Promising Future with Strategic Initiatives and Strong Financial Position Justifying Buy Rating
12d ago
ATAI
Premium
The Fly
Psychedelic: atai Life Sciences, Cybin report earnings results
12d ago
ATAI
CYBN
Premium
The Fly
Atai Life Sciences reports Q2 EPS (14c), consensus (12c)
12d ago
ATAI
Premium
The Fly
Atai Life Sciences price target raised to $16 from $14 at Oppenheimer
25d ago
ATAI
Premium
The Fly
Psychedelic: Filament reports compassionate use approval for psilocybin
26d ago
PBM
ATAI
Premium
Ratings
ATAI Life Sciences: Strategic Positioning and Diversified Portfolio Drive Buy Rating
27d ago
ATAI
Premium
The Fly
Atai Life Sciences price target raised to $15 from $10 at H.C. Wainwright
27d ago
ATAI
Premium
The Fly
Sarepta upgraded, Tapestry downgraded: Wall Street’s top analyst calls
28d ago
CF
EW
Premium
The Fly
Atai Life Sciences initiated with an Outperform at Oppenheimer
28d ago
ATAI
Premium
The Fly
Morning Movers: Venture Global and Cheniere rise following U.S.-EU trade deal
29d ago
VG
BOH
Premium
Ratings
ATAI Life Sciences: Strategic Focus on BPL-003 Amid Setbacks Offers Investment Opportunity
29d ago
ATAI
Premium
The Fly
Atai Life Sciences price target lowered to $11 from $12 at Canaccord
29d ago
ATAI
Premium
The Fly
Recognify provides update on Phase 2b trial of inidascamine
1M ago
ATAI
Premium
Ratings
ATAI Life Sciences: Promising Phase 2b Results and Strong Financial Position Boost Price Target
2M ago
ATAI
Premium
The Fly
Psychedelic: atai Life Sciences, Beckley Psytech report BPL-003 study results
2M ago
ATAI
CMND
Premium
The Fly
Atai Life Sciences price target raised to $12 from $11 at Canaccord
2M ago
ATAI
Premium
The Fly
Cathie Wood’s ARK Investment buys 949.6K shares of Atai Life Sciences today
2M ago
ATAI
Premium
The Fly
Atai data supports ‘best-in-class potential’ of BPL-003, says H.C. Wainwright
2M ago
ATAI
Premium
The Fly
Morning Movers: Tesla dips as Musk and Trump resume feud
2M ago
SG
DYN
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
